Effect of Pini Folium Extract on AP-1 (c-fos/c-jun) in Cancer Cells

암세포에서 송엽의 AP-l (c-fos/c-jun)에 미치는 영향

  • 박건구 (아산생명과학연구소 분자유전연구실) ;
  • 장혜숙 (울산대학교 의과대학) ;
  • 이정교 (울산대학교 의과대학) ;
  • 최승훈 (경희대학교 한의과대학)
  • Published : 1999.02.01

Abstract

Phorbol ester, growth factors activities are mediated by unclear transcription factors, the c-Fos and c-Jun, which can regulate transcriptional activation through specific DNA sites and by forming the transcription factor AP-l, which usually mediates cell proliferation and differentiation signals. We explored effects of Pini Folium extract (API-l) on AP-l activity. Western blot analysis confirmed that API-l decreased levels of c-Fos or c-Jun protein induced by the tumor promoter Phorbol 12-myristate 13-acetate (PMA; 200 nM). Transient transfection assays with a c-fos promoter reporter construct showed that API-l decreased transcription activity by ore than 50~60%. However, treatment of API-l activity studied further. The main substances were fractionated into dichloromethane layer. Futhermore, API-l extract repressed the [$^3H$]-thymidine uptake in C6 glioma cells, indicating that this extract could be included in a new type of modulator in the mitogenesis.

Keywords

References

  1. Cell v.56 he leucine repeat motif in fos protein modiates complex formation with Jun/AP-1 and is required for Transformation Schuermann M.;Neuberg M.;Hunter J. B.;Jenuwein T.;Ryseck R. P.;Bravo R.;Muler R.
  2. Cell v.54 The c-fos protein interacts with c-jun/AP-1 to stimulate transcription of AP-1 responsive genes Chiu R.;Boyle W. J.;Meek J.;Smeal T.;Hunter T.;Karin M.
  3. Oncogene v.7 Transformation by Jun: requirement for leucine zipper, basic region and transactivation domin and enhancement by Fos Morgan I. M.;Ransone, L. J.;Bos T. J.;Verma I. M.;Vogt P. K.
  4. Cell v.54 Requirement ofr fos gene expression in the transcription activation of collagenase by other oncogenes and pholbol esters Schonthal A.;Herrlich P.;Rahmsdorf H. J.;Ponta H.
  5. Proc. Natl. Acad. Sci. USA v.88 The nuclear protooncogenes c-jun and c-fos as regulators of DNA replication Murakami Y.;Satake M.;Yamaguchi-Iwai Y.;Sakai M.;Muramatsu M.;Ito Y.
  6. Mol. Cell. Biol. v.11 The Jun and Fos protein families are both required for cell cycle progression in fibroblast Kovary K.;Bravo R.
  7. Bioessays v.17 Modulation of AP-1/ATF transcription factor activity by the adenovirus-E1A oncogene products Hagmeyer B. M.;Angel P.;van Dam H.
  8. Proc. Natl. Acad. Sci. USA v.89 Induction of c-jun protooncogene expression and transcription factor AP-1 activity by the polyoma virus middle-sized tumor antigen Schonthal A.;Srinivas S.;Eckhart W.
  9. Nature v.346 Negative regulation of human c-fos expression by the retinoblastoma gene product Robbins P. D.;Horowitz J. M.;Mulligan R. C.
  10. Cell v.82 c-for is required for malignant progression of skin tumors Saez, E.;Rutberg, S. E.;Mueller, E.;Oppenheim, H.;Smoluk, J.;Yuspa, S. H.;Spiegelman B. M.
  11. Cell v.62 Antitumor promotion and anti-inflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone Jonat, C.;Rahmsdorf, H.;park, K.-K.;Cato, A. B. C.'Gebel, S.;Ponta, H.;Herrlich, P.
  12. Mol. Cell. biol. v.13 Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro Kerppola T. K.;Luk, D.;Curran T.
  13. Oncogene v.12 Overex-pression of both RAR and RXR restores AP-1 repression in ovarian adenocarcinoma cells resistant to retinoic acid-dependent growth inhibition Soprano D. R.;Chen L. X.;Wu, S.;donigan A. M.;Borghaei R. C.;Soprno K. J.
  14. Human & Exp. Toxic. v.14 no.2 The ying-yang of RAR and AP-1: cancer treatment without overt toxicity Allenby G.
  15. Anti-Cancer Drugs v.6 Inhibition of breast and ovarian carcinoma cell growth by 1, 25-dihydroxyvitamin D3 combined with retinoic acid or dexamethasone Saunders D. E.;Christensen C.;Wiliams, J. R.;Wappler N. L.;Lawrence W. D.;Malone J. M.;Malviya V. K.;Deppe G.
  16. Oncogene v.9 Retinoic acid suppresses polyoma virus transformation by inhibiting transcription of the c-fos proto-oncogene Talmage D. A.;Listerud M.
  17. Cancer Res. v.56 Inhibition of tumor promoter-induced transformation by retinoids that transrepress AP-1 without transactivating retinoic acid response element Li, J. J.;Dong Z.;Dawson M. I.;Colburn N. H.
  18. 향약(생약)대사전 정보섭(외)
  19. unpublished results Park, K.-K
  20. Carcinogenesis v.16 Signal integration at the c-fos promoter Janknecht R.;Cahill M. A.;Nordheim A.
  21. Nature v.334 Induction of proto-oncogene Jun/AP-1 by serum and TPA Lamph W. W.;Wamsley P.;Sassone-Corse P.;Verma I. M.
  22. Mol. Cell. Biol. v.15 Doxorubicine-induced Id2A gene transcription is targeted at an activating transcription factor/cyclic AMP prsponse element motif through novel mechanism involving protein kinases distinct from protein kinase C and protein kinase A.